Politico reported Tuesday that the Trump administration is trying to secure an emergency use authorization from the Food and Drug Administration for Fujifilm's Avigan. The FDA gave an EUA to two unproven antimalarial drugs over the weekend.
Study results showed AbbVie's Kaletra did no better than standard treatment. Meanwhile, a generic version of Fujifilm's Avigan, which the NIH said it is considering, showed signs of efficacy, though some regulators are skeptical of the flu drug.
The home care industry is booming. As Baby Boomers age and more families seek in-home solutions for loved ones, demand for home care services is at an all-time high.